Key Benefits: Improves blood sugar control Promotes significant weight loss Provides cardiovascular protection Shows anti-inflammatory properties Slows gastric emptying and enhances satiety Key Drawbacks: Common gastrointestinal side effects (nausea, diarrhea, constipation) Rare but serious GI disorders (e.g., pancreatitis) May interfere with absorption of other medications Potential eye-related risks (rare optic nerve issues) Cosmetic changes such as Ozempic face after rapid weight loss Takeaway: Ozempic is a powerful tool for diabetes and obesity management, but it requires careful monitoring, individualized assessment, and shared decision-making between physician and patient
GLP-1 medications are prescription drugs that should be taken and monitored under the supervision of a licensed health care professional
In people without diabetes (normal blood sugar), Vildagliptin does not stimulate insulin secretion or cause a decrease in glucose levels
A detailed consultation helps determine whether the treatment is appropriate for you
Warfarin, metabolized primarily by CYP2C9, would have a different pharmacokinetic risk profile but the same pharmacodynamic overlap regarding bleeding
&srotate=0)
